Loading…

Axially Chiral N-Benzyl-N,7-dimethyl-5-phenyl-1,7-naphthyridine-6-carboxamide Derivatives as Tachykinin NK1 Receptor Antagonists:  Determination of the Absolute Stereochemical Requirements

A potent and orally active NK1 antagonist, trans-N-[3,5-bis(trifluoromethyl)benzyl]-7,8-dihydro-N,7-dimethyl-5-(4-methylphenyl)-8-oxo-1,7-naphthyridine-6-carboxamide (1 t ), was shown to exist as a mixture of separable and stable (R)- and (S)-atropisomers (1 t -A and 1 t -B) originating from the res...

Full description

Saved in:
Bibliographic Details
Published in:Journal of medicinal chemistry 1998-10, Vol.41 (22), p.4232-4239
Main Authors: Ikeura, Yoshinori, Ishichi, Yuji, Tanaka, Toshimasa, Fujishima, Akira, Murabayashi, Mika, Kawada, Mitsuru, Ishimaru, Takenori, Kamo, Izumi, Doi, Takayuki, Natsugari, Hideaki
Format: Article
Language:English
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page 4239
container_issue 22
container_start_page 4232
container_title Journal of medicinal chemistry
container_volume 41
creator Ikeura, Yoshinori
Ishichi, Yuji
Tanaka, Toshimasa
Fujishima, Akira
Murabayashi, Mika
Kawada, Mitsuru
Ishimaru, Takenori
Kamo, Izumi
Doi, Takayuki
Natsugari, Hideaki
description A potent and orally active NK1 antagonist, trans-N-[3,5-bis(trifluoromethyl)benzyl]-7,8-dihydro-N,7-dimethyl-5-(4-methylphenyl)-8-oxo-1,7-naphthyridine-6-carboxamide (1 t ), was shown to exist as a mixture of separable and stable (R)- and (S)-atropisomers (1 t -A and 1 t -B) originating from the restricted rotation around the −C(6)−C(O)− bond; the antagonistic activities of 1 t -A were ca. 6−13-fold higher than those of 1 t -B. Analogues of 1 t (3), which have (S)- and (R)-methyl groups at the benzylic methylene portion of 1 t , were prepared and separated into the diastereomeric atropisomers, 3a-A, 3a-B and 3b-A, 3b-B, in enantiomerically pure forms. Among the four isomers of 3, the (aR,S)-enantiomer (3a-A) exhibited the most potent antagonistic activities with an IC50 value of 0.80 nM (in vitro inhibition of [125I]BH-SP binding in human IM-9 cells) and ED50 values of 9.3 μg/kg (iv) and 67.7 μg/kg (po) (in vivo inhibition of capsaicin-induced plasma extravasation in guinea pig trachea), while the activity of the (aS,R)-enantiomer (3b-B) was the weakest with an IC50 value of 620 nM. The structure−activity relationships in this series of antagonists indicate that the (R)-configuration at the axial bond and the stacking (or stacking-like) conformation between the two phenyl rings as shown in 1 t -A and 3a-A are essential for high-affinity binding and suggest that the amide moiety functions as a hydrogen bond acceptor in the interaction with the receptor.
doi_str_mv 10.1021/jm980042m
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_69988395</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>69988395</sourcerecordid><originalsourceid>FETCH-LOGICAL-a371t-120e54313fb920a6e3c5bba9ab6e152ada7b614b27c456df501a892a6212677e3</originalsourceid><addsrcrecordid>eNo9ks2O0zAUhSMEGsrAggdA8gJYYfBPEifsSvkVo4JmisTOukluiDuJk7GdUcuKLS_Fw_AkGLXqyvY53726PrpJ8pizl5wJ_mo7lAVjqRjuJAueCUbTgqV3kwVjQlCRC3k_eeD9ljEmuZBnyVmpipSVxSL5s9wZ6Ps9WXXGQU_W9A3an_uerl8o2pgBQxcfGZ06tPHCo2ph6qLqTGMs0pzW4KpxB4NpkLxFZ24hmFv0BDzZQN3tr401lqw_c3KJNU5hdGRpA_wYrfHBv_7763csC-gGY2PlaMnYktAhWVZ-7OeA5CqaONYdDqaOI17izWwcDmiDf5jca6H3-Oh4niff3r_brD7Siy8fPq2WFxSk4oFywTBLJZdtVQoGOco6qyooocox5gUNqCrnaSVUnWZ502aMQ1EKyAUXuVIoz5Pnh76TG29m9EEPxtfY92BxnL3Oy7IoZJlF8MkRnKsBGz05M4Db62Pg0X969MHHz7QObG38CROpVKJgEaMHLEaEu5MN7lrnSqpMb75e6dVGiZIXXH-P_LMDD7XX23F2NqahOdP_10Of1kP-Aw2ArJE</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>69988395</pqid></control><display><type>article</type><title>Axially Chiral N-Benzyl-N,7-dimethyl-5-phenyl-1,7-naphthyridine-6-carboxamide Derivatives as Tachykinin NK1 Receptor Antagonists:  Determination of the Absolute Stereochemical Requirements</title><source>American Chemical Society:Jisc Collections:American Chemical Society Read &amp; Publish Agreement 2022-2024 (Reading list)</source><creator>Ikeura, Yoshinori ; Ishichi, Yuji ; Tanaka, Toshimasa ; Fujishima, Akira ; Murabayashi, Mika ; Kawada, Mitsuru ; Ishimaru, Takenori ; Kamo, Izumi ; Doi, Takayuki ; Natsugari, Hideaki</creator><creatorcontrib>Ikeura, Yoshinori ; Ishichi, Yuji ; Tanaka, Toshimasa ; Fujishima, Akira ; Murabayashi, Mika ; Kawada, Mitsuru ; Ishimaru, Takenori ; Kamo, Izumi ; Doi, Takayuki ; Natsugari, Hideaki</creatorcontrib><description>A potent and orally active NK1 antagonist, trans-N-[3,5-bis(trifluoromethyl)benzyl]-7,8-dihydro-N,7-dimethyl-5-(4-methylphenyl)-8-oxo-1,7-naphthyridine-6-carboxamide (1 t ), was shown to exist as a mixture of separable and stable (R)- and (S)-atropisomers (1 t -A and 1 t -B) originating from the restricted rotation around the −C(6)−C(O)− bond; the antagonistic activities of 1 t -A were ca. 6−13-fold higher than those of 1 t -B. Analogues of 1 t (3), which have (S)- and (R)-methyl groups at the benzylic methylene portion of 1 t , were prepared and separated into the diastereomeric atropisomers, 3a-A, 3a-B and 3b-A, 3b-B, in enantiomerically pure forms. Among the four isomers of 3, the (aR,S)-enantiomer (3a-A) exhibited the most potent antagonistic activities with an IC50 value of 0.80 nM (in vitro inhibition of [125I]BH-SP binding in human IM-9 cells) and ED50 values of 9.3 μg/kg (iv) and 67.7 μg/kg (po) (in vivo inhibition of capsaicin-induced plasma extravasation in guinea pig trachea), while the activity of the (aS,R)-enantiomer (3b-B) was the weakest with an IC50 value of 620 nM. The structure−activity relationships in this series of antagonists indicate that the (R)-configuration at the axial bond and the stacking (or stacking-like) conformation between the two phenyl rings as shown in 1 t -A and 3a-A are essential for high-affinity binding and suggest that the amide moiety functions as a hydrogen bond acceptor in the interaction with the receptor.</description><identifier>ISSN: 0022-2623</identifier><identifier>EISSN: 1520-4804</identifier><identifier>DOI: 10.1021/jm980042m</identifier><identifier>PMID: 9784098</identifier><identifier>CODEN: JMCMAR</identifier><language>eng</language><publisher>Washington, DC: American Chemical Society</publisher><subject>Administration, Oral ; Animals ; Biological and medical sciences ; Capillary Permeability - drug effects ; Capsaicin ; Cell Line ; Crystallography, X-Ray ; Guinea Pigs ; Humans ; Injections, Intravenous ; Medical sciences ; Models, Molecular ; Molecular Conformation ; Naphthyridines - administration &amp; dosage ; Naphthyridines - chemical synthesis ; Naphthyridines - chemistry ; Naphthyridines - pharmacology ; Neurokinin-1 Receptor Antagonists ; Neuropharmacology ; Neurotransmitters. Neurotransmission. Receptors ; Peptidergic system (neuropeptide, opioid peptide, opiates...). Adenosinergic and purinergic systems ; Pharmacology. Drug treatments ; Stereoisomerism ; Trachea - blood supply ; Trachea - drug effects</subject><ispartof>Journal of medicinal chemistry, 1998-10, Vol.41 (22), p.4232-4239</ispartof><rights>Copyright © 1998 American Chemical Society</rights><rights>1998 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27922,27923</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=2437280$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/9784098$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ikeura, Yoshinori</creatorcontrib><creatorcontrib>Ishichi, Yuji</creatorcontrib><creatorcontrib>Tanaka, Toshimasa</creatorcontrib><creatorcontrib>Fujishima, Akira</creatorcontrib><creatorcontrib>Murabayashi, Mika</creatorcontrib><creatorcontrib>Kawada, Mitsuru</creatorcontrib><creatorcontrib>Ishimaru, Takenori</creatorcontrib><creatorcontrib>Kamo, Izumi</creatorcontrib><creatorcontrib>Doi, Takayuki</creatorcontrib><creatorcontrib>Natsugari, Hideaki</creatorcontrib><title>Axially Chiral N-Benzyl-N,7-dimethyl-5-phenyl-1,7-naphthyridine-6-carboxamide Derivatives as Tachykinin NK1 Receptor Antagonists:  Determination of the Absolute Stereochemical Requirements</title><title>Journal of medicinal chemistry</title><addtitle>J. Med. Chem</addtitle><description>A potent and orally active NK1 antagonist, trans-N-[3,5-bis(trifluoromethyl)benzyl]-7,8-dihydro-N,7-dimethyl-5-(4-methylphenyl)-8-oxo-1,7-naphthyridine-6-carboxamide (1 t ), was shown to exist as a mixture of separable and stable (R)- and (S)-atropisomers (1 t -A and 1 t -B) originating from the restricted rotation around the −C(6)−C(O)− bond; the antagonistic activities of 1 t -A were ca. 6−13-fold higher than those of 1 t -B. Analogues of 1 t (3), which have (S)- and (R)-methyl groups at the benzylic methylene portion of 1 t , were prepared and separated into the diastereomeric atropisomers, 3a-A, 3a-B and 3b-A, 3b-B, in enantiomerically pure forms. Among the four isomers of 3, the (aR,S)-enantiomer (3a-A) exhibited the most potent antagonistic activities with an IC50 value of 0.80 nM (in vitro inhibition of [125I]BH-SP binding in human IM-9 cells) and ED50 values of 9.3 μg/kg (iv) and 67.7 μg/kg (po) (in vivo inhibition of capsaicin-induced plasma extravasation in guinea pig trachea), while the activity of the (aS,R)-enantiomer (3b-B) was the weakest with an IC50 value of 620 nM. The structure−activity relationships in this series of antagonists indicate that the (R)-configuration at the axial bond and the stacking (or stacking-like) conformation between the two phenyl rings as shown in 1 t -A and 3a-A are essential for high-affinity binding and suggest that the amide moiety functions as a hydrogen bond acceptor in the interaction with the receptor.</description><subject>Administration, Oral</subject><subject>Animals</subject><subject>Biological and medical sciences</subject><subject>Capillary Permeability - drug effects</subject><subject>Capsaicin</subject><subject>Cell Line</subject><subject>Crystallography, X-Ray</subject><subject>Guinea Pigs</subject><subject>Humans</subject><subject>Injections, Intravenous</subject><subject>Medical sciences</subject><subject>Models, Molecular</subject><subject>Molecular Conformation</subject><subject>Naphthyridines - administration &amp; dosage</subject><subject>Naphthyridines - chemical synthesis</subject><subject>Naphthyridines - chemistry</subject><subject>Naphthyridines - pharmacology</subject><subject>Neurokinin-1 Receptor Antagonists</subject><subject>Neuropharmacology</subject><subject>Neurotransmitters. Neurotransmission. Receptors</subject><subject>Peptidergic system (neuropeptide, opioid peptide, opiates...). Adenosinergic and purinergic systems</subject><subject>Pharmacology. Drug treatments</subject><subject>Stereoisomerism</subject><subject>Trachea - blood supply</subject><subject>Trachea - drug effects</subject><issn>0022-2623</issn><issn>1520-4804</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1998</creationdate><recordtype>article</recordtype><recordid>eNo9ks2O0zAUhSMEGsrAggdA8gJYYfBPEifsSvkVo4JmisTOukluiDuJk7GdUcuKLS_Fw_AkGLXqyvY53726PrpJ8pizl5wJ_mo7lAVjqRjuJAueCUbTgqV3kwVjQlCRC3k_eeD9ljEmuZBnyVmpipSVxSL5s9wZ6Ps9WXXGQU_W9A3an_uerl8o2pgBQxcfGZ06tPHCo2ph6qLqTGMs0pzW4KpxB4NpkLxFZ24hmFv0BDzZQN3tr401lqw_c3KJNU5hdGRpA_wYrfHBv_7763csC-gGY2PlaMnYktAhWVZ-7OeA5CqaONYdDqaOI17izWwcDmiDf5jca6H3-Oh4niff3r_brD7Siy8fPq2WFxSk4oFywTBLJZdtVQoGOco6qyooocox5gUNqCrnaSVUnWZ502aMQ1EKyAUXuVIoz5Pnh76TG29m9EEPxtfY92BxnL3Oy7IoZJlF8MkRnKsBGz05M4Db62Pg0X969MHHz7QObG38CROpVKJgEaMHLEaEu5MN7lrnSqpMb75e6dVGiZIXXH-P_LMDD7XX23F2NqahOdP_10Of1kP-Aw2ArJE</recordid><startdate>19981022</startdate><enddate>19981022</enddate><creator>Ikeura, Yoshinori</creator><creator>Ishichi, Yuji</creator><creator>Tanaka, Toshimasa</creator><creator>Fujishima, Akira</creator><creator>Murabayashi, Mika</creator><creator>Kawada, Mitsuru</creator><creator>Ishimaru, Takenori</creator><creator>Kamo, Izumi</creator><creator>Doi, Takayuki</creator><creator>Natsugari, Hideaki</creator><general>American Chemical Society</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>19981022</creationdate><title>Axially Chiral N-Benzyl-N,7-dimethyl-5-phenyl-1,7-naphthyridine-6-carboxamide Derivatives as Tachykinin NK1 Receptor Antagonists:  Determination of the Absolute Stereochemical Requirements</title><author>Ikeura, Yoshinori ; Ishichi, Yuji ; Tanaka, Toshimasa ; Fujishima, Akira ; Murabayashi, Mika ; Kawada, Mitsuru ; Ishimaru, Takenori ; Kamo, Izumi ; Doi, Takayuki ; Natsugari, Hideaki</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a371t-120e54313fb920a6e3c5bba9ab6e152ada7b614b27c456df501a892a6212677e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1998</creationdate><topic>Administration, Oral</topic><topic>Animals</topic><topic>Biological and medical sciences</topic><topic>Capillary Permeability - drug effects</topic><topic>Capsaicin</topic><topic>Cell Line</topic><topic>Crystallography, X-Ray</topic><topic>Guinea Pigs</topic><topic>Humans</topic><topic>Injections, Intravenous</topic><topic>Medical sciences</topic><topic>Models, Molecular</topic><topic>Molecular Conformation</topic><topic>Naphthyridines - administration &amp; dosage</topic><topic>Naphthyridines - chemical synthesis</topic><topic>Naphthyridines - chemistry</topic><topic>Naphthyridines - pharmacology</topic><topic>Neurokinin-1 Receptor Antagonists</topic><topic>Neuropharmacology</topic><topic>Neurotransmitters. Neurotransmission. Receptors</topic><topic>Peptidergic system (neuropeptide, opioid peptide, opiates...). Adenosinergic and purinergic systems</topic><topic>Pharmacology. Drug treatments</topic><topic>Stereoisomerism</topic><topic>Trachea - blood supply</topic><topic>Trachea - drug effects</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ikeura, Yoshinori</creatorcontrib><creatorcontrib>Ishichi, Yuji</creatorcontrib><creatorcontrib>Tanaka, Toshimasa</creatorcontrib><creatorcontrib>Fujishima, Akira</creatorcontrib><creatorcontrib>Murabayashi, Mika</creatorcontrib><creatorcontrib>Kawada, Mitsuru</creatorcontrib><creatorcontrib>Ishimaru, Takenori</creatorcontrib><creatorcontrib>Kamo, Izumi</creatorcontrib><creatorcontrib>Doi, Takayuki</creatorcontrib><creatorcontrib>Natsugari, Hideaki</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of medicinal chemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ikeura, Yoshinori</au><au>Ishichi, Yuji</au><au>Tanaka, Toshimasa</au><au>Fujishima, Akira</au><au>Murabayashi, Mika</au><au>Kawada, Mitsuru</au><au>Ishimaru, Takenori</au><au>Kamo, Izumi</au><au>Doi, Takayuki</au><au>Natsugari, Hideaki</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Axially Chiral N-Benzyl-N,7-dimethyl-5-phenyl-1,7-naphthyridine-6-carboxamide Derivatives as Tachykinin NK1 Receptor Antagonists:  Determination of the Absolute Stereochemical Requirements</atitle><jtitle>Journal of medicinal chemistry</jtitle><addtitle>J. Med. Chem</addtitle><date>1998-10-22</date><risdate>1998</risdate><volume>41</volume><issue>22</issue><spage>4232</spage><epage>4239</epage><pages>4232-4239</pages><issn>0022-2623</issn><eissn>1520-4804</eissn><coden>JMCMAR</coden><abstract>A potent and orally active NK1 antagonist, trans-N-[3,5-bis(trifluoromethyl)benzyl]-7,8-dihydro-N,7-dimethyl-5-(4-methylphenyl)-8-oxo-1,7-naphthyridine-6-carboxamide (1 t ), was shown to exist as a mixture of separable and stable (R)- and (S)-atropisomers (1 t -A and 1 t -B) originating from the restricted rotation around the −C(6)−C(O)− bond; the antagonistic activities of 1 t -A were ca. 6−13-fold higher than those of 1 t -B. Analogues of 1 t (3), which have (S)- and (R)-methyl groups at the benzylic methylene portion of 1 t , were prepared and separated into the diastereomeric atropisomers, 3a-A, 3a-B and 3b-A, 3b-B, in enantiomerically pure forms. Among the four isomers of 3, the (aR,S)-enantiomer (3a-A) exhibited the most potent antagonistic activities with an IC50 value of 0.80 nM (in vitro inhibition of [125I]BH-SP binding in human IM-9 cells) and ED50 values of 9.3 μg/kg (iv) and 67.7 μg/kg (po) (in vivo inhibition of capsaicin-induced plasma extravasation in guinea pig trachea), while the activity of the (aS,R)-enantiomer (3b-B) was the weakest with an IC50 value of 620 nM. The structure−activity relationships in this series of antagonists indicate that the (R)-configuration at the axial bond and the stacking (or stacking-like) conformation between the two phenyl rings as shown in 1 t -A and 3a-A are essential for high-affinity binding and suggest that the amide moiety functions as a hydrogen bond acceptor in the interaction with the receptor.</abstract><cop>Washington, DC</cop><pub>American Chemical Society</pub><pmid>9784098</pmid><doi>10.1021/jm980042m</doi><tpages>8</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0022-2623
ispartof Journal of medicinal chemistry, 1998-10, Vol.41 (22), p.4232-4239
issn 0022-2623
1520-4804
language eng
recordid cdi_proquest_miscellaneous_69988395
source American Chemical Society:Jisc Collections:American Chemical Society Read & Publish Agreement 2022-2024 (Reading list)
subjects Administration, Oral
Animals
Biological and medical sciences
Capillary Permeability - drug effects
Capsaicin
Cell Line
Crystallography, X-Ray
Guinea Pigs
Humans
Injections, Intravenous
Medical sciences
Models, Molecular
Molecular Conformation
Naphthyridines - administration & dosage
Naphthyridines - chemical synthesis
Naphthyridines - chemistry
Naphthyridines - pharmacology
Neurokinin-1 Receptor Antagonists
Neuropharmacology
Neurotransmitters. Neurotransmission. Receptors
Peptidergic system (neuropeptide, opioid peptide, opiates...). Adenosinergic and purinergic systems
Pharmacology. Drug treatments
Stereoisomerism
Trachea - blood supply
Trachea - drug effects
title Axially Chiral N-Benzyl-N,7-dimethyl-5-phenyl-1,7-naphthyridine-6-carboxamide Derivatives as Tachykinin NK1 Receptor Antagonists:  Determination of the Absolute Stereochemical Requirements
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-14T09%3A42%3A34IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Axially%20Chiral%20N-Benzyl-N,7-dimethyl-5-phenyl-1,7-naphthyridine-6-carboxamide%20Derivatives%20as%20Tachykinin%20NK1%20Receptor%20Antagonists:%E2%80%89%20Determination%20of%20the%20Absolute%20Stereochemical%20Requirements&rft.jtitle=Journal%20of%20medicinal%20chemistry&rft.au=Ikeura,%20Yoshinori&rft.date=1998-10-22&rft.volume=41&rft.issue=22&rft.spage=4232&rft.epage=4239&rft.pages=4232-4239&rft.issn=0022-2623&rft.eissn=1520-4804&rft.coden=JMCMAR&rft_id=info:doi/10.1021/jm980042m&rft_dat=%3Cproquest_pubme%3E69988395%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-a371t-120e54313fb920a6e3c5bba9ab6e152ada7b614b27c456df501a892a6212677e3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=69988395&rft_id=info:pmid/9784098&rfr_iscdi=true